Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial
<p>Abstract</p> <p>Background</p> <p>Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or m...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
BMC
2011-07-01
|
| 丛编: | BMC Pregnancy and Childbirth |
| 在线阅读: | http://www.biomedcentral.com/1471-2393/11/50 |
| _version_ | 1830351280755703808 |
|---|---|
| author | Sporken Jan M J Perquin Denise A M Franssen Maureen T M Wijnen-Duvekot Ella J Willekes Christine Oosterbaan Herman P van Huizen Marloes E van Beek Erik Groot Christianne Bloemenkamp Kitty W Oudijk Martijn A Porath Martina Groen Henk van Kaam Anton H van Pampus Maria G van Baaren Gert-Jan Broekhuijsen Kim Langenveld Josje Woiski Mallory D Bremer Henk A Papatsonis Dimitri N M Brons Jozien T J Kaplan Mesruwe Nij Bijvanck Bas W A Mol Ben-Willen J |
| author_facet | Sporken Jan M J Perquin Denise A M Franssen Maureen T M Wijnen-Duvekot Ella J Willekes Christine Oosterbaan Herman P van Huizen Marloes E van Beek Erik Groot Christianne Bloemenkamp Kitty W Oudijk Martijn A Porath Martina Groen Henk van Kaam Anton H van Pampus Maria G van Baaren Gert-Jan Broekhuijsen Kim Langenveld Josje Woiski Mallory D Bremer Henk A Papatsonis Dimitri N M Brons Jozien T J Kaplan Mesruwe Nij Bijvanck Bas W A Mol Ben-Willen J |
| author_sort | Sporken Jan M J |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or maternal death. We recently showed that in women with GH or mild PE at term induction of labour reduces both high risk situations for mothers as well as the caesarean section rate. In view of this knowledge, one can raise the question whether women with severe hypertension, pre-eclampsia or deterioration chronic hypertension between 34 and 37 weeks of gestation should be delivered or monitored expectantly. Induction of labour might prevent maternal complications. However, induction of labour in late pre-term pregnancy might increase neonatal morbidity and mortality compared with delivery at term.</p> <p>Methods/Design</p> <p>Pregnant women with severe gestational hypertension, mild pre-eclampsia or deteriorating chronic hypertension at a gestational age between 34<sup>+0 </sup>and 36<sup>+6 </sup>weeks will be asked to participate in a multi-centre randomised controlled trial. Women will be randomised to either induction of labour or expectant monitoring. In the expectant monitoring arm, women will be induced only when the maternal or fetal condition detoriates or at 37<sup>+0 </sup>weeks of gestation. The primary outcome measure is a composite endpoint of maternal mortality, severe maternal complications (eclampsia, HELLP syndrome, pulmonary oedema and thromboembolic disease) and progression to severe pre-eclampsia. Secondary outcomes measures are respiratory distress syndrome (RDS), neonatal morbidity and mortality, caesarean section and vaginal instrumental delivery rates, maternal quality of life and costs. Analysis will be intention to treat. The power calculation is based on an expectant reduction of the maternal composite endpoint from 5% to 1% for an expected increase in neonatal RDS from 1% at 37 weeks to 10% at 34 weeks. This implies that 680 women have to be randomised.</p> <p>Discussion</p> <p>This trial will provide insight as to whether in women with hypertensive disorders late pre-term, induction of labour is an effective treatment to prevent severe maternal complications without compromising the neonatal morbidity.</p> <p>Trial Registration</p> <p><a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=NTR1792">NTR1792</a> Clinical trial registration: <url>http://www.trialregister.nl</url></p> |
| first_indexed | 2024-12-20T00:35:21Z |
| format | Article |
| id | doaj.art-b067b51e7f45425db8e5d4420f2d8d3e |
| institution | Directory Open Access Journal |
| issn | 1471-2393 |
| language | English |
| last_indexed | 2024-12-20T00:35:21Z |
| publishDate | 2011-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pregnancy and Childbirth |
| spelling | doaj.art-b067b51e7f45425db8e5d4420f2d8d3e2022-12-21T19:59:46ZengBMCBMC Pregnancy and Childbirth1471-23932011-07-011115010.1186/1471-2393-11-50Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trialSporken Jan M JPerquin Denise A MFranssen Maureen T MWijnen-Duvekot Ella JWillekes ChristineOosterbaan Herman Pvan Huizen Marloes Evan Beek ErikGroot ChristianneBloemenkamp Kitty WOudijk Martijn APorath MartinaGroen Henkvan Kaam Anton Hvan Pampus Maria Gvan Baaren Gert-JanBroekhuijsen KimLangenveld JosjeWoiski Mallory DBremer Henk APapatsonis Dimitri N MBrons Jozien T JKaplan MesruweNij Bijvanck Bas W AMol Ben-Willen J<p>Abstract</p> <p>Background</p> <p>Gestational hypertension (GH) and pre-eclampsia (PE) can result in severe complications such as eclampsia, placental abruption, syndrome of Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) and ultimately even neonatal or maternal death. We recently showed that in women with GH or mild PE at term induction of labour reduces both high risk situations for mothers as well as the caesarean section rate. In view of this knowledge, one can raise the question whether women with severe hypertension, pre-eclampsia or deterioration chronic hypertension between 34 and 37 weeks of gestation should be delivered or monitored expectantly. Induction of labour might prevent maternal complications. However, induction of labour in late pre-term pregnancy might increase neonatal morbidity and mortality compared with delivery at term.</p> <p>Methods/Design</p> <p>Pregnant women with severe gestational hypertension, mild pre-eclampsia or deteriorating chronic hypertension at a gestational age between 34<sup>+0 </sup>and 36<sup>+6 </sup>weeks will be asked to participate in a multi-centre randomised controlled trial. Women will be randomised to either induction of labour or expectant monitoring. In the expectant monitoring arm, women will be induced only when the maternal or fetal condition detoriates or at 37<sup>+0 </sup>weeks of gestation. The primary outcome measure is a composite endpoint of maternal mortality, severe maternal complications (eclampsia, HELLP syndrome, pulmonary oedema and thromboembolic disease) and progression to severe pre-eclampsia. Secondary outcomes measures are respiratory distress syndrome (RDS), neonatal morbidity and mortality, caesarean section and vaginal instrumental delivery rates, maternal quality of life and costs. Analysis will be intention to treat. The power calculation is based on an expectant reduction of the maternal composite endpoint from 5% to 1% for an expected increase in neonatal RDS from 1% at 37 weeks to 10% at 34 weeks. This implies that 680 women have to be randomised.</p> <p>Discussion</p> <p>This trial will provide insight as to whether in women with hypertensive disorders late pre-term, induction of labour is an effective treatment to prevent severe maternal complications without compromising the neonatal morbidity.</p> <p>Trial Registration</p> <p><a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=NTR1792">NTR1792</a> Clinical trial registration: <url>http://www.trialregister.nl</url></p>http://www.biomedcentral.com/1471-2393/11/50 |
| spellingShingle | Sporken Jan M J Perquin Denise A M Franssen Maureen T M Wijnen-Duvekot Ella J Willekes Christine Oosterbaan Herman P van Huizen Marloes E van Beek Erik Groot Christianne Bloemenkamp Kitty W Oudijk Martijn A Porath Martina Groen Henk van Kaam Anton H van Pampus Maria G van Baaren Gert-Jan Broekhuijsen Kim Langenveld Josje Woiski Mallory D Bremer Henk A Papatsonis Dimitri N M Brons Jozien T J Kaplan Mesruwe Nij Bijvanck Bas W A Mol Ben-Willen J Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial BMC Pregnancy and Childbirth |
| title | Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial |
| title_full | Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial |
| title_fullStr | Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial |
| title_full_unstemmed | Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial |
| title_short | Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial |
| title_sort | induction of labour versus expectant monitoring for gestational hypertension or mild pre eclampsia between 34 and 37 weeks gestation hypitat ii a multicentre open label randomised controlled trial |
| url | http://www.biomedcentral.com/1471-2393/11/50 |
| work_keys_str_mv | AT sporkenjanmj inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT perquindeniseam inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT franssenmaureentm inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT wijnenduvekotellaj inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT willekeschristine inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT oosterbaanhermanp inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT vanhuizenmarloese inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT vanbeekerik inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT grootchristianne inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT bloemenkampkittyw inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT oudijkmartijna inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT porathmartina inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT groenhenk inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT vankaamantonh inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT vanpampusmariag inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT vanbaarengertjan inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT broekhuijsenkim inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT langenveldjosje inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT woiskimalloryd inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT bremerhenka inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT papatsonisdimitrinm inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT bronsjozientj inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT kaplanmesruwe inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT nijbijvanckbaswa inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial AT molbenwillenj inductionoflabourversusexpectantmonitoringforgestationalhypertensionormildpreeclampsiabetween34and37weeksgestationhypitatiiamulticentreopenlabelrandomisedcontrolledtrial |